An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007 ·
http://www.medpagetoday.com/Cardiology/PCI/tb/5319An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007 ·
http://www.medpagetoday.com/Cardiology/PCI/tb/5319